A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

NCT06461156 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic NSCLC

Interventions

DRUG: HS-10504

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.